Skip to main content
. 2020 Nov 23;4(4):e376–e382. doi: 10.1055/s-0040-1720962

Fig. 1.

Fig. 1

Adapted institutional anticoagulation guideline for the management of COVID-19-induced coagulopathy in ICU patients. AKI, acute kidney injury; aPTT, activated partial thromboplastin time; COVID-19, novel coronavirus disease 2019; DIC, disseminated intravascular coagulation; DOAC, direct oral anticoagulant; SIC, SIC, sepsis-induced coagulopathy; UFH, unfractionated heparin; VTE, venous thromboembolism.